Systematic review and meta-analysis on neurodevelopmental outcomes after necrotizing enterocolitis in preterm infants
Preterm babies who survive NEC face lasting brain and body challenges
This systematic review and meta-analysis synthesized evidence on neurodevelopmental outcomes for infants born before 34 weeks who survive ne…
Preterm infants who survive NEC face a higher risk of lasting developmental delays, especially in motor skills, vision, and hearing, accordi…
Network meta-analysis of drain placement for chronic subdural hematoma recurrence and mortality
Where Surgeons Should Place Drains After Brain Bleed Surgery
This systematic review and network meta-analysis synthesized evidence from 14 articles on drain placement for chronic subdural hematoma. It …
A new analysis of over 4,000 patients reveals that placing a drain under the scalp, not the brain, dramatically lowers the chance of bleedin…
Mini review discusses Minor Neurological Signs in children within child neurology and psychiatry settings
Minor Neurological Signs May Help Track Child Brain Health
This mini review examines Minor Neurological Signs (MNS) in children within child neurology and psychiatry settings. The authors note that M…
Subtle neurological signs in children could reveal hidden brain issues, but more research is needed.
Narrative review discusses jump assessment for multiple sclerosis disability evaluation
Jump tests offer a new way to track multiple sclerosis disability
This narrative review examines the use of jump assessment, including vertical jump tests and countermovement jumps, for evaluating people wi…
A review suggests simple jump tests might help measure disability in multiple sclerosis better than traditional clinical tools like the Expa…
Guideline-based clinical pathway for trans-sectoral support in severe neuro-disability: a qualitative exploratory study
New Care Plan Helps People With Severe Brain Injuries at Home
This qualitative exploratory study informed a guideline-based clinical pathway for trans-sectoral specialist support by regional outreach fo…
A new clinical pathway connects hospital specialists with community therapists to improve care for people with severe neuro-disabilities liv…
FDA Approves Ocrevus (ocrelizumab) for Relapsing and Primary Progressive Multiple Sclerosis
FDA approves Ocrevus, a new drug for two forms of multiple sclerosis.
FDA approved Ocrevus (ocrelizumab) for relapsing forms of MS (including clinically isolated syndrome, relapsing-remitting disease, and activ…
The FDA approved Ocrevus (ocrelizumab) to treat relapsing forms of MS and primary progressive MS (PPMS) in adults. It is the first drug appr…
Meta-analysis of preclinical studies suggests ligustrazine improves outcomes in cerebral ischemia-reperfusion injury
New data shows Ligustrazine helps brain recovery after stroke-like events in animals
This meta-analysis of preclinical animal studies evaluated ligustrazine for cerebral ischemia-reperfusion injury. Pooled results from 381 an…
New research suggests a specific plant compound could help the brain recover after blood flow is restored following a blockage
Meta-analysis links acute kidney injury to increased stroke, delirium, and dementia risk
Kidney Injury Today Linked to Higher Stroke and Dementia Risk Tomorrow
This systematic review and meta-analysis synthesized data from 11,253,825 participants on associations between acute kidney injury and subse…
New research shows kidney injury dramatically increases later dementia risk even after recovery surprising many who thought kidneys and brai…
Meta-analysis of GLP-1 agonists for Parkinson's disease motor symptoms shows limited benefit
A recent review found no clear benefit for Parkinsons disease patients taking GLP-1 drugs compared to placebo
This meta-analysis of randomized trials examined GLP-1 receptor agonists for Parkinson's disease. It found no statistically significant impr…
A new analysis of studies shows GLP-1 drugs did not improve movement or daily life for people with Parkinsons disease. While quality of life…
Ocrelizumab treatment in multiple sclerosis shows disability improvement in relapsing forms
MS Drugs Stop Relapses But Miss This Silent Disability Threat
This retrospective longitudinal cohort study analyzed 1859 people with multiple sclerosis treated with ocrelizumab. Disability improvement w…
• Top MS drugs fix sudden relapses but not slow nerve damage • Helps people with all MS types facing hidden progression • Not a new treatmen…
Systematic review of DBS for freezing of gait in Parkinson's disease
Deep Brain Stimulation Eases Freezing in Parkinson's at Key Moments
This systematic review and meta-analysis synthesized evidence on deep brain stimulation for freezing of gait in Parkinson's disease. The aut…
When Parkinson's medication stops working, deep brain stimulation can help people who suddenly freeze while walking, especially during their…
Systematic review and meta-analysis of dual-task walking in adults with dementia shows slower speed and shorter steps versus controls
New Walking Tests Reveal Hidden Dementia Signs Before Memory Fails
This systematic review and meta-analysis evaluates instrumented dual-task paradigms versus single-task conditions in adults with clinically …
• Movement changes during thinking tasks signal early dementia • Helps people worried about memory loss get earlier answers • Still needs te…